The results demonstrated that increased expression of evf‐2 leads to podocyte mitosis and inflammation, and podocyte‐specific knockout of evf‐2 alleviates podocyte injury induced by LPS or DN. The gene discussed is DLX6-AS1; the disease is liver dysplastic nodule.